MedTrace Logo

A Treat-to-target Strategy Using Pan-enteric Capsule Endoscopy (PCE) in Paediatric Crohn's Disease (CD).

NCT03161886 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2018-01-08

No results posted yet for this study

Summary

This prospective, interventional study aims this to determine the efficacy and safety of a PCE-based treat-to-target strategy in order to achieve Mucosal Healing (MH) and deep remission (DR) of pediatric Crohn's Disease (CD) over 52 weeks.

Conditions

  • Inflammatory Bowel Diseases
  • Children, Only

Interventions

DEVICE

Pan-enteric Capsule Endoscopy (PCE)

Second generation of colon capsule endoscopy (Medtronic)

Sponsors & Collaborators

  • Azienda Policlinico Umberto I

    lead OTHER

Principal Investigators

  • Salvatore Oliva, MD · Sapienza - University of Rome, Azienda Policlinico Umberto I

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
6 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-01
Primary Completion
2016-12-01
Completion
2017-01-10

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03161886 on ClinicalTrials.gov